Strong correlations between circulating chemerin levels and lipoprotein subfractions in nondiabetic obese and nonobese subjects

Clinical Endocrinology

Volumn 81, Issue 3, 2014, Pages 370-377

  Lórincz, Hajnalka ^a   Katkõ, Mõnika ^a   Harangi, Mariann ^a   Somodi, Sándor ^a   Gaál, Krisztina ^a   Fülöp, Péter ^a   Paragh, György ^a   Seres, Ildikõ ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMERIN, HUMAN; CHEMOKINE; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MIDDLE AGED; OBESITY;

ADULT; CHEMOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OBESITY;

EID: 84905126660     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12363     Document Type: Article

References (30)

1. Blüher, M., (2012) Clinical relevance of adipokines. Diabetes & Metabolism Journal, 36, 317-327.
2. Bozaoglu, K., Bolton, K., McMillan, J., et al,. (2007) Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology, 148, 4687-4694.
3. Zabel, B.A., Allen, S.J., Kulig, P., et al,. (2005) Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. Journal of Biological Chemistry, 280, 34661-34666.
4. Luangsay, S., Wittamer, V., Bondue, B., et al,. (2009) Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model. Journal of Immunology, 183, 6489-6499.
5. Ernst, M.C., &, Sinal, C.J., (2010) Chemerin: at the crossroads of inflammation and obesity. Trends in Endocrinology and Metabolism, 21, 660-667.
6. Goralski, K.B., McCarthy, T.C., Hanniman, E.A., et al,. (2007) Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. Journal of Biological Chemistry, 282, 28175-28188.
7. Shin, H.Y., Lee, D.C., Chu, S.H., et al,. (2012) Chemerin levels are positively correlated with abdominal visceral fat accumulation. Clinical Endocrinology, 77, 47-50.
8. Xiaotao, L., Xiaoxia, Z., Yue, X., et al,. (2012) Serum chemerin levels are associated with the presence and extent of coronary artery disease. Coronary Artery Disease, 23, 412-416.
9. Jialal, I., Devaraj, S., Kaur, H., et al,. (2013) Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. Journal of Clinical Endocrinology and Metabolism, 98, E514-E517.
10. Sell, H., Divoux, A., Poitou, C., et al,. (2010) Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. Journal of Clinical Endocrinology and Metabolism, 95, 2892-2896.
11. Krauss, R.M., (2010) Lipoprotein subfractions and cardiovascular disease risk. Current Opinion in Lipidology, 21, 305-311.
12. Mertens, A., &, Holvoet, P., (2001) Oxidized LDL and HDL: antagonists in atherothrombosis. Federation of American Societies for Experimental Biology journal, 15, 2073-2084.
13. Kontush, A., &, Chapman, M.J., (2006) Antiatherogenic small, dense HDL-guardian angel of the arterial wall? Nature Clinical Practice Cardiovascular Medicine, 3, 144-153.
14. Matthews, D.R., Hosker, J.P., Rudenski, A.S., et al,. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
15. Krauss, R.M., (1995) Dense low density lipoproteins and coronary artery disease. American Journal of Cardiology, 75, 53B-57B.
16. Superko, H.R., Pendyala, L., Williams, P.T., et al,. (2012) High-density lipoprotein subclasses and their relationship to cardiovascular disease. Journal of Clinical Lipidology, 6, 496-523.
17. Laakso, M., Lehto, S., Penttilä, I., et al,. (1993) Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation, 88, 1421-1430.
18. Sledzinski, T., Korczynska, J., Hallmann, A., et al,. (2013) The increase of serum chemerin concentration is mainly associated with the increase of BMI in obese, non-diabetic subjects. Journal of Endocrinological Investigation, 36, 428-434.
19. Yang, M., Yang, G., Dong, J., et al,. (2010) Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension. Journal of Investigative Medicine, 58, 883-886.
20. Weigert, J., Neumeier, M., Wanninger, J., et al,. (2010) Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clinical Endocrinology, 72, 342-348.
21. Lehrke, M., Becker, A., Greif, M., et al,. (2009) Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. European Journal of Endocrinology, 161, 339-344.
22. Kim, S.H., Lee, S.H., Ahn, K.Y., et al,. (2013) Effect of lifestyle modification on serum chemerin concentration and its association with insulin sensitivity in overweight and obese adults with type 2 diabetes. Clinical Endocrinology. doi: 10.1111/cen.12249. [Epub ahead of print].
23. El-Mesallamy, H.O., El-Derany, M.O., &, Hamdy, N.M., (2011) Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease. Diabetic Medicine, 28, 1194-1200.
24. Spiroglou, S.G., Kostopoulos, C.G., Varakis, J.N., et al,. (2010) Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis. Journal of Atherosclerosis and Thrombosis, 17, 115-130.
25. Lo Prete, A.C., Dina, C.H., Azevedo, C.H., et al,. (2009) In vitro simultaneous transfer of lipids to HDL in coronary artery disease and in statin treatment. Lipids, 44, 917-924.
26. Holzer, M., Birner-Gruenberger, R., Stojakovic, T., et al,. (2011) Uremia alters HDL composition and function. Journal of the American Society of Nephrology, 22, 1631-1641.
27. Berrougui, H., Momo, C.N., &, Khalil, A., (2012) Health benefits of high-density lipoproteins in preventing cardiovascular diseases. Journal of Clinical Lipidology, 6, 524-533.
28. Yu, Y., Sheth, N., Krishnamoorthy, P., et al,. (2012) Aortic vascular inflammation in psoriasis is associated with HDL particle size and concentration: a pilot study. American Journal of Cardiovascular Disease, 2, 285-292.
29. Rye, K.A., &, Barter, P.J., (2013) Cardioprotective functions of HDL. Journal of Lipid Research. doi: 10.1194/jlr.R039297 [Epub ahead of print].
30. Barter, P.J., Nicholls, S., Rye, K.A., et al,. (2013) Antiinflammatory properties of HDL. Circulation Research, 95, 764-772.